Gillian M. Cannon's most recent trade in Corcept Therapeutics Inc was a trade of 15,000 Stock option (right to buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Xenon Pharmaceuticals Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 17,012 | 17,012 | - | - | Share Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 2,645 | 2,645 | - | - | Restricted Share Units | |
| Xenon Pharmaceuticals Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 15,542 | 15,542 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Xenon Pharmaceuticals Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 28,000 | 28,000 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2023 | 30,000 | 30,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 20,000 | 20,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Gillian M. Cannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) |